5,979
Views
42
CrossRef citations to date
0
Altmetric
Research Article

Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model

, , , , , , , , , & show all
Article: 1757360 | Received 13 Sep 2019, Accepted 25 Dec 2019, Published online: 13 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Tingyu Liang, Yixuan Song, Lingui Gu, Yu Wang & Wenbin Ma. (2023) Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma. International Journal of General Medicine 16, pages 4121-4141.
Read now
Pierre-Antoine Laurent, Daphne Morel, Lydia Meziani, Stephane Depil & Eric Deutsch. (2023) Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumors. OncoImmunology 12:1.
Read now
Nicolina Jovanovich, Ahmed Habib, NU Farrukh Hameed, Lincoln Edwards & Pascal O Zinn. (2023) Applications and Current Challenges of Chimeric Antigen Receptor T Cells in Treating High-Grade Gliomas in Adult and Pediatric Populations. Immunotherapy 15:5, pages 383-396.
Read now

Articles from other publishers (39)

Yolanda Santiago-Vicente, Manuel de Jesús Castillejos-López, Liliana Carmona-Aparicio, Elvia Coballase-Urrutia, Liliana Velasco-Hidalgo, Ana María Niembro-Zúñiga, Marta Zapata-Tarrés & Luz María Torres-Espíndola. (2024) Immunotherapy for Pediatric Gliomas: CAR-T Cells Against B7H3: A Review of the Literature. CNS & Neurological Disorders - Drug Targets 23:4, pages 420-430.
Crossref
Deqiang Deng, Tianli Hao, Lisen Lu, Muyang Yang, Zhen Zeng, Jonathan F. Lovell, Yushuai Liu & Honglin Jin. (2024) Applications of Intravital Imaging in Cancer Immunotherapy. Bioengineering 11:3, pages 264.
Crossref
Minmin Wang, Linzi Jia, Xiangpeng Dai & Xiaoling Zhang. (2024) Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy . Molecular Oncology.
Crossref
Elena Obrador, Paz Moreno-Murciano, María Oriol-Caballo, Rafael López-Blanch, Begoña Pineda, Julia Gutiérrez-Arroyo, Alba Loras, Luis Gonzalez-Bonet, Conrado Martinez-Cadenas, José Estrela & María Marqués-Torrejón. (2024) Glioblastoma Therapy: Past, Present and Future. International Journal of Molecular Sciences 25:5, pages 2529.
Crossref
Tim Bozic & Bostjan Markelc. 2024. Mouse Models of Cancer. Mouse Models of Cancer 137 155 .
Jie He, Yushan Yan, Jun Zhang, Zhiming Wei, Huashun Li & Ligang Xing. (2023) Synergistic treatment strategy: combining CAR-NK cell therapy and radiotherapy to combat solid tumors. Frontiers in Immunology 14.
Crossref
Longwei Liu, Chi Woo Yoon, Zhou Yuan, Tianze Guo, Yunjia Qu, Peixiang He, Xi Yu, Ziyue Zhu, Praopim Limsakul & Yingxiao Wang. (2023) Cellular and molecular imaging of CAR-T cell-based immunotherapy. Advanced Drug Delivery Reviews 203, pages 115135.
Crossref
Weihua Liu, Yu Zhao, Zhongfeng Liu, Guangji Zhang, Huantong Wu, Xin Zheng, Xihe Tang & Zhiguo Chen. (2023) Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK. Cellular Oncology 46:6, pages 1747-1762.
Crossref
Senbo Liu, Wenkang Wang, Shengyun Hu, Bin Jia, Baojing Tuo, Haifeng Sun, Qiming Wang, Yang Liu & Zhenqiang Sun. (2023) Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity. Cell Death & Disease 14:10.
Crossref
Marco Ventin, Giulia Cattaneo, Luke Maggs, Jingyu Jia, Shahrzad Arya, Soldano Ferrone, Xinhui Wang & Cristina R. Ferrone. (2023) B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancers. Frontiers in Oncology 13.
Crossref
Kai Kang, Yijun Wu, Zhuoran Yao & You Lu. (2023) Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy. Cancer Letters 565, pages 216239.
Crossref
Limei Yin, Zhengwei Wan, Ping Sun, Ping Shuai & Yuping Liu. (2023) Time to abandon CAR-T monotherapy for solid tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:4, pages 188930.
Crossref
Siyu Guo, Yihan Yao, Yang Tang, Zengfeng Xin, Dang Wu, Chao Ni, Jian Huang, Qichun Wei & Ting Zhang. (2023) Radiation-induced tumor immune microenvironments and potential targets for combination therapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
Liqiang Zhong, Yi Li, Tobias Muluh & Yongsheng Wang. (2023) Combination of CAR‑T cell therapy and radiotherapy: Opportunities and challenges in solid tumors (Review). Oncology Letters 26:1.
Crossref
Jorge Almagro & Hendrik A. Messal. (2023) Volume imaging to interrogate cancer cell-tumor microenvironment interactions in space and time. Frontiers in Immunology 14.
Crossref
Chaoqun Wang, Yuntao Li, Lijuan Gu, Ran Chen, Hua Zhu, Xu Zhang, Yonggang Zhang, Shi Feng, Sheng Qiu, Zhihong Jian & Xiaoxing Xiong. (2023) Gene Targets of CAR-T Cell Therapy for Glioblastoma. Cancers 15:8, pages 2351.
Crossref
Haonan Li, Qiang Luo, Hu Zhang, Xuelei Ma, Zhongwei Gu, Qiyong Gong & Kui Luo. (2023) Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation. Chemical Society Reviews 52:1, pages 47-96.
Crossref
Rui Sun & Albert H. Kim. (2022) The multifaceted mechanisms of malignant glioblastoma progression and clinical implications. Cancer and Metastasis Reviews 41:4, pages 871-898.
Crossref
Tessa Gargett, Lisa M Ebert, Nga T H Truong, Paris M Kollis, Kristyna Sedivakova, Wenbo Yu, Erica C F Yeo, Nicole L Wittwer, Briony L Gliddon, Melinda N Tea, Rebecca Ormsby, Santosh Poonnoose, Jake Nowicki, Orazio Vittorio, David S Ziegler, Stuart M Pitson & Michael P Brown. (2022) GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma. Journal for ImmunoTherapy of Cancer 10:9, pages e005187.
Crossref
Mika L Persson, Alicia M Douglas, Frank Alvaro, Pouya Faridi, Martin R Larsen, Marta M Alonso, Nicholas A Vitanza & Matthew D Dun. (2022) The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies. Neuro-Oncology 24:9, pages 1408-1422.
Crossref
Hamed Arami, Siavash Kananian, Layla Khalifehzadeh, Chirag B. Patel, Edwin Chang, Yuji Tanabe, Yitian Zeng, Steven J. Madsen, Michael J. Mandella, Arutselvan Natarajan, Eric E. Peterson, Robert Sinclair, Ada S. Y. Poon & Sanjiv Sam Gambhir. (2022) Remotely controlled near-infrared-triggered photothermal treatment of brain tumours in freely behaving mice using gold nanostars. Nature Nanotechnology 17:9, pages 1015-1022.
Crossref
Ravian L van Ineveld, Esmée J van Vliet, Ellen J Wehrens, Maria Alieva & Anne C Rios. (2022) 3D imaging for driving cancer discovery. The EMBO Journal 41:10.
Crossref
Elena Codrici, Ionela-Daniela Popescu, Cristiana Tanase & Ana-Maria Enciu. (2022) Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment. International Journal of Molecular Sciences 23:5, pages 2509.
Crossref
Pavlina Chuntova, Yafei Hou, Ryosuke Naka, Akane Yamamichi, Tiffany Chen, Yitzhar Goretsky, Ryusuke Hatae, Takahide Nejo, Gary Kohanbash, Abigail L Mende, Megan Montoya, Kira M Downey, David Diebold, Jayne Skinner, Hong-Erh Liang, Bjoern Schwer & Hideho Okada. (2022) Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice. Neuro-Oncology 24:2, pages 259-272.
Crossref
Mahdi Abdoli Shadbad, Nima Hemmat, Vahid Khaze Shahgoli, Afshin Derakhshani, Farzad Baradaran, Oronzo Brunetti, Rossella Fasano, Renato Bernardini, Nicola Silvestris & Behzad Baradaran. (2022) A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine. Frontiers in Immunology 12.
Crossref
Vicky Mengfei Qin, Nicole M. Haynes, Criselle D’Souza, Paul J. Neeson & Joe Jiang Zhu. (2022) CAR-T Plus Radiotherapy: A Promising Combination for Immunosuppressive Tumors. Frontiers in Immunology 12.
Crossref
Josephine Zhang & Jesús A Siller-Farfán. (2022) Current and future perspectives of chimeric antigen receptors against glioblastoma. Immunotherapy Advances 2:1.
Crossref
Noha Attia, Mohamed Mashal, Sudhakar Pemminati, Adekunle Omole, Carolyn Edmondson, Will Jones, Priyanka Priyadarshini, Temoria Mughal, Pauline Aziz, Blesing Zenick, Ambar Perez & Morgan Lacken. (2021) Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies. Cells 11:1, pages 116.
Crossref
Hongyun Zhao, Fan Luo, Jinhui Xue, Su Li & Rui-Hua Xu. (2021) Emerging immunological strategies: recent advances and future directions. Frontiers of Medicine 15:6, pages 805-828.
Crossref
Pauline Thomas, Natacha Galopin, Emma Bonérandi, Béatrice Clémenceau, Sophie Fougeray & Stéphane Birklé. (2021) CAR T Cell Therapy’s Potential for Pediatric Brain Tumors. Cancers 13:21, pages 5445.
Crossref
Malvina Prapa, Chiara Chiavelli, Giulia Golinelli, Giulia Grisendi, Marco Bestagno, Rosanna Di Tinco, Massimiliano Dall’Ora, Giovanni Neri, Olivia Candini, Carlotta Spano, Tiziana Petrachi, Laura Bertoni, Gianluca Carnevale, Giuseppe Pugliese, Roberta Depenni, Alberto Feletti, Corrado Iaccarino, Giacomo Pavesi & Massimo Dominici. (2021) GD2 CAR T cells against human glioblastoma. npj Precision Oncology 5:1.
Crossref
Yao Sun, Yongfeng Su, Yizhi Wang, Na Liu, Yuhang Li, Jianlin Chen, Zhuoqing Qiao, Jingwen Niu, Jiangwei Hu, Bin Zhang, Hongmei Ning & Liangding Hu. (2021) CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report. Frontiers in Immunology 12.
Crossref
Kendelle J. Murphy, Daniel A. Reed, Michael Trpceski, David Herrmann & Paul Timpson. (2021) Quantifying and visualising the nuances of cellular dynamics in vivo using intravital imaging. Current Opinion in Cell Biology 72, pages 41-53.
Crossref
Wei Wu, Jessica L. Klockow, Michael Zhang, Famyrah Lafortune, Edwin Chang, Linchun Jin, Yang Wu & Heike E. Daldrup-Link. (2021) Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacological Research 171, pages 105780.
Crossref
Chirayu R. Chokshi, Benjamin A. Brakel, Nazanin Tatari, Neil Savage, Sabra K. Salim, Chitra Venugopal & Sheila K. Singh. (2021) Advances in Immunotherapy for Adult Glioblastoma. Cancers 13:14, pages 3400.
Crossref
Navin K. Chintala, David Restle, Hue Quach, Jasmeen Saini, Rebecca Bellis, Michael Offin, Jason Beattie & Prasad S. Adusumilli. (2021) CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical trials. Lung Cancer 157, pages 48-59.
Crossref
Dalia Haydar, Haley Houke, Jason Chiang, Zhongzhen Yi, Zelda Odé, Kenneth Caldwell, Xiaoyan Zhu, Kimberly S Mercer, Jennifer L Stripay, Timothy I Shaw, Peter Vogel, Christopher DeRenzo, Suzanne J Baker, Martine F Roussel, Stephen Gottschalk & Giedre Krenciute. (2021) Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery. Neuro-Oncology 23:6, pages 999-1011.
Crossref
Feifei Guo & Jiuwei Cui. (2021) CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation. Cancers 13:8, pages 1955.
Crossref
Mengdan Ma, Yuchen Liu & Weiren Huang. (2021) Applications of CRISPR-Cas System in Tumor Biology. Oncologie 23:4, pages 463-492.
Crossref